DOI: 10.1055/s-00000005

Aktuelle Rheumatologie

References

Ruperto N. et al.
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.

Ann Rheum Diss 2018;
77: 1710-1719

Download Bibliographical Data

Search in: